METABOLIC-ASSOCIATED STEATOHEPATITIS: HOW NEW DRUGS ARE CHANGING THE GAME

Metabolic-Associated Steatohepatitis: How New Drugs Are Changing the Game The Turning Point: How REZDIFFRA’s Approval is Revolutionizing MASH Treatment The approval of Rezdiffra represents a significant breakthrough in the metabolic-associated steatohepatitis (MASH) therapeutic landscape, redefining treatment approaches. Unlike conventional str